naialabs uses microfluidic technology to perform immunoassays enabling measurement of antibody or protein biomarkers using reduced sample and reagent volumes with a high-throughput, automated approach.
Requiring only a few nanoliters of sample per assay, our technology allows multiple tests to be performed from a single drop of blood collected at home using existing, certified microsampling devices.
Owing to its unique capabilities, we envision that naialabs’ platform will simplify population-based academic and pharmaceutical research, offer opportunities in testing biomarkers for customer-initiated health assessment, and facilitate the diagnosis of both infectious and noncommunicable diseases.
